The Cholesterol Control Supplements Market is estimated to be worth USD 1,021.01 million by 2024. It is projected to reach USD 1,540.67 million by 2034, reflecting a CAGR of 4.6% over the assessment period 2024 to 2034.
The cholesterol control supplements market is growing rapidly, driven by increasing awareness of cardiovascular health and a shift toward preventive care. Supplements like omega-3 fatty acids, plant sterols, and soluble fiber are popular for managing cholesterol levels.
A recent survey indicates that 68% of consumers prefer natural supplements over pharmaceuticals for cholesterol management, with 45% willing to pay a premium for clinically backed products. The market is segmented between MNCs, which dominate the premium sector with patented formulations, and private labels offering affordable options.
The market for Cholesterol Control Supplements is segmented by functionality, each aimed at unique cholesterol health advantages. The primary segment focuses on reducing Low-Density Lipoprotein (LDL) or "bad" cholesterol which is a major contributor to heart disease and atherosclerosis.
This includes sub-segments that have plant sterols and niacin soluble fibres all of which help to lower LDL. Another sub-segment is HDL Cholesterol enhancement is increases High-Density Lipoprotein (HDL, "good" cholesterol) which helps remove excess cholesterol from the bloodstream. That has included sub-segments that claim to do this contain niacin, monounsaturated fats, and other substances that raise HDL levels.
Another functionality segmented is focused on reducing triglycerides, which are another type of fat that is related to heart disease risks. Which provides a protective effect against the heart disease.
In addition, the consumer moves towards unhealthy lifestyles due to this increase in cholesterol levels. It is a common cause of high LDL cholesterol or low HDL cholesterol. Due to the cholesterol level increase in the risk of heart disease and stroke, as a result, increase the death rate. According to WHO approximately 2.6 million deaths thus, 4.5% disability-adjusted life years.
High Cholesterol causes 3.6 million deaths every year It is a major risk factor for heart disease and stroke in both high- and low-income countries. As a result, there is a growing demand for cholesterol control supplements.
Consumers are becoming more health-conscious and affluent and are prepared to pay for more quality supplement. Cholesterol control products range from improving may reducing LDL cholesterol, may lowering LDL cholesterol it may protect from heart disease.
Supplements are included in various forms such as Capsules, Tablets, Softgels, Powders, and others. In addition, new technologies that have been adopted into the healthcare industry and production have resulted in quality supplements being more available and affordable which enhanced industry expansion.
| Attributes | Description |
|---|---|
| Estimated Cholesterol Control Supplements Market Size (2024E) | USD 1,021.01 million |
| Projected Cholesterol Control Supplements Market Value (2034F) | USD 1,540.67 million |
| Value-based CAGR (2024 to 2034) | 4.6 % |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Rising awareness of health and presentation among consumer against cardiovascular disease is driving the market growth.
According to numerous studies, sedentary lifestyles combined with unhealthy habits like smoking, drinking high quantities of alcohol, and eating foods that are heavily laced with fat have also been on the rise in cardiovascular disease rates.
The Looming Catastrophe of Cardiovascular Diseases (CVD) According to the World Health Origination (WHO) is a situation where almost every year 17.9 million people die due to heart-related diseases. In addition, according to the Centers for Disease Control and Prevention (CDC) in the United States in 2021, heart disease explained 1 of every 5 deaths, of which over 695,000 are dead.
Thus, as there is an increased incidence of cardiovascular disease among the population there is an increased prevalence of health supplements consumption to sustain good health and also due to this reason, there is increased interest in healthy heart and healthy aging.
Some Key companies are increasingly adding new solutions to their product portfolio which has increasing demand for cardiovascular health supplements for instance, OptiBiotix has launched the OptiBiotix Health PLC to tackle obesity, cardiovascular disease, and diabetes, to target cholesterol.
The increasing application of cholesterol control supplements has driven the market growth.
Cholesterol control supplements included on the physician’s recommendation, such as Omega-3 Fatty Acids, Berberine, Plant Sterols/Stanols, Fish Oil, green tea, or green tea extract, may be applied. Omega-3 Fatty Acids may decrease low-density lipoprotein (LDL or bad) cholesterol and triglycerides because Omega-3 fatty acids are healthy fats that may support heart health and triglycerides.
As awareness of these health benefits, rising demand for cardiovascular supplements containing omega fatty acids for health has risen substantially in the study, participants in the study who consumed 2 grams of plant stanols every day for a year as a result that experienced a decrease in LDL cholesterol by over 10%. For instance, according to a research review published today in the Journal of the American Heart Association Consuming 3 grams of omega-3 fatty acids daily, through a source such as a supplement or food has been shown to reduce blood pressure. As a result, increasing applications of cholesterol management supplements have driven the growth of the cholesterol control supplement market.
Increase trend of traditional medicine, has been driving the increase in herbal supplements for controlling cholesterol supplement.
Herbal supplements are commonly used as complementary and alternative medicine (CAM) and have seen an ever-increasing trend in the last three decades among the population. Meditation herbal supplements are promoted by general consumer for well-being weight loss, immunity, mental and physical health claims.
The use of herbal medicines and phytonutrients or nutraceuticals continues to grow rapidly across the world with many consumer turning to these products for treatment of control cholesterol and other health challenges in different national healthcare settings.
Some companies are continuously developing new product launches for instance ORGANIC INDIA Lipid Care has to introduce Lipid Care Capsules to control total cholesterol, Lipid Care Capsules help to maintain healthy cardiovascular functions & normal cholesterol levels. In Addition, in 2023, Nutrartis introduced Cardiosmile Plant Sterols in the USA market.
The product is available in a liquid sachet and can be used effectively in the management of cholesterol and heart health. In addition, some of the herbal supplements that may help to lower cholesterol include Garlic, Fiber, Whey protein, Policosanol, and Others. This trend has driven cholesterol control supplements in the global market.
Global sales increased at a CAGR of 3.0 % from 2019 to 2023. For the next ten years (2024 to 2034), projections are that expenditure on such products will rise at 4.6 % CAGR. Sales were particularly robust in developed markets, where consumer awareness and disposable income supported demand for premium, clinically backed products.
Emerging markets also contributed to growth, with private label brands providing affordable options. Market growth during this period was supported by innovations such as omega-3 and phytosterol-enriched formulations, and the expansion of e-commerce further enhanced accessibility.
FMI Analysis states that demand for cholesterol control supplements from 2024 to 2034 is projected to accelerate, driven by aging populations and a growing prevalence of lifestyle-related health conditions. The market is expected to expand at a CAGR of 4.6%. Increasing consumer inclination toward personalized nutrition and supplements tailored to individual health profiles will further drive growth.
Additionally, regulatory support for clinically proven ingredients and rising adoption of these supplements in Asia-Pacific markets are expected to contribute significantly to future demand.
Principal Consultant
The cholesterol control supplements market shows a clear divide between private label players and multinational corporations (MNCs) in terms of strategies and market focus. Private label brands primarily compete on price, targeting cost-conscious consumers with affordable options.
Retailers are promoting their in-house brands through loyalty programs, attractive shelf placements, and localized formulations including ingredients like plant sterols or garlic extracts.
These brands save on advertising costs by relying on retailer-driven promotions, focusing on straightforward claims and functional benefits to attract consumers at the point of sale. Their affordability and accessibility making them particularly appealing in developing markets where price sensitivity is high.
In contrast, MNCs like Nestlé and Abbott dominate are leveraging their strong brand equity and consumer trust along with brand identity. They differentiate themselves through innovation, heavily investing in R&D to create scientifically validated formulations such as omega-3 or phytosterol-enriched supplements.
Their marketing strategies include aggressive campaigns across multiple channels, endorsements from healthcare professionals, and partnerships with pharmacies and e-commerce platforms to ensure broad distribution. By emphasizing clinical studies and the superior efficacy of their products, MNCs appeal to health-conscious consumers willing to pay a premium for quality and proven results. This dual approach by private labels and MNCs creates a balanced yet competitive market landscape.
The following table shows the estimated growth rates of the key three territories.
| Country | CAGR, 2024 to 2034 |
|---|---|
| USA | 6.5% |
| India | 4.3% |
| China | 5.5% |
The growth of online platforms and the development of retail networks have made cholesterol supplements more accessible to a broader number of consumer.
The surge in healthcare demand within the United States serves as a driver for online platforms. The USA retail industry, exploding with online sales. This growth has included e-commerce, such as Walgreens is the online shop with the highest e-commerce net sales merchandising in pharmacy products in the USA with revenue of 1.8 billion USA dollars. In 2024 Pfizer Inc. introduced Pfizer for all end-to-end service in the United States.
This design is a user-friendly digital platform that offers a wide variety of services, including home delivery, appointment scheduling, and others. This helps to the accessibility of cholesterol control supplements. In recent years USA retail pharmacy has grown by pharmacy service, easily available to consumers, increasing demand for over-the-counter products. This increasing health concern, and growing awareness of preventative healthcare, are driving the demand for cholesterol control supplements in the USA market.
The rise in cholesterol-related issues due to the growing population and unhealthy lifestyle habits has led to an increased demand for the cholesterol control supplement market in India.
The rise in cholesterol-related issues in India can be attributed to a combination of factors, primarily the growing population and changing lifestyle habits. As India’s population continues to expand, more individuals are becoming susceptible to various health concerns, including those linked to elevated cholesterol levels.
Cholesterol-related problems, such as high LDL (bad cholesterol) and low HDL (good cholesterol), are a significant risk factor for cardiovascular diseases, diabetes, and stroke, which are among the leading causes of death in the country.
A significant contributor to this rise in cholesterol issues is the shift in lifestyle habits. Rapid urbanization, coupled with the adoption of a Westernized diet, has led to increased consumption of processed foods, high-fat diets, and sugary beverages, all of which are major contributors to cholesterol imbalances.
In addition, sedentary lifestyles, with limited physical activity, have further exacerbated the problem. Work-related stress, irregular sleep patterns, and an increase in smoking and alcohol consumption also play critical roles in contributing to elevated cholesterol levels.
As awareness of the health risks associated with high cholesterol grows, there is a noticeable surge in demand for cholesterol control supplements in the Indian market. These supplements, which often contain natural ingredients like plant sterols, omega-3 fatty acids, and antioxidants, offer an accessible and non-invasive alternative to managing cholesterol levels.
The increasing health-consciousness among consumers, particularly among the urban middle class, has fueled the demand for preventive health measures, and cholesterol control supplements have gained popularity as part of this trend.
The Chinese government's focus on preventive healthcare as a part of its Healthy China in 2030 initiative has been driving adoption of cholesterol control supplement products.
Chinese consumers are now searching for suitable supplements that control heart disease and control cholesterol levels with a variety. Such demands have further caused the emergence of processed, supplements. Another key factor is the intensification and diversification of government initiatives. As the profits are made by manufacturers expand their production by introducing more supplements into it.
In addition, the development of a ‘Healthy China’ is prominent to the Chinese Government’s agenda for health and development and has the possibility to huge benefits for the rest of the world. With chronic disease rates on the rise, the government focuses on boosting health wellness is driven demand for cholesterol control supplements.
With the rise in chronic disease rates globally, China’s focus on preventive healthcare offers a model that could lead to significant benefits both within China and internationally. The growing demand for cholesterol control supplements is a direct result of these efforts, and the market is expected to expand as health-conscious consumers continue to seek effective, accessible solutions for maintaining heart health.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Omega-3 Fatty Acids (By Product Type) |
|---|---|
| Value Share (2024) | 23.4% |
Manufacturers are increasingly focusing on omega-3 fatty acids as a key ingredient in cholesterol control supplements, reflecting their proven efficacy in supporting heart health and managing cholesterol levels. In 2024, omega-3 fatty acids are projected to hold a significant 23.4% value share of the cholesterol control supplement market, underscoring their dominance in the segment.
The popularity of omega-3 products is driven by their ability to reduce triglyceride levels and support overall cardiovascular health, making them a preferred choice among health-conscious consumers.
This growth is further fueled by strong consumer awareness campaigns, clinical backing, and the availability of diverse product formats, including capsules, soft gels, and functional foods. Major manufacturers are leveraging sustainable sources, such as algae-based omega-3, to appeal to environmentally conscious consumers.
The rising demand for plant-based omega-3 supplements is also contributing to the segment's growth, particularly among vegan and vegetarian consumers. This strategic focus on omega-3 ingredients positions manufacturers to cater to evolving consumer preferences and maintain competitiveness in the cholesterol control market.
| Segment | Capsules(By Product Forms) |
|---|---|
| Value Share (2024) | 24.6 % |
Capsules are projected to account for 24.6% of the value share in the cholesterol control supplement market by 2024, making them the most preferred product form in this segment. Their dominance is attributed to the convenience they offer in terms of precise dosage, portability, and ease of use, appealing to a broad consumer base.
Capsules also provide superior encapsulation of active ingredients such as omega-3 fatty acids, phytosterols, and soluble fibers, ensuring product stability and efficacy.
Manufacturers are innovating within this segment by introducing vegan capsules made from plant-based materials to meet the growing demand from health-conscious and environmentally aware consumers. Furthermore, capsules with delayed-release technology are gaining popularity for improved absorption and targeted benefits.
The high adoption rate of capsules underscores their role as a versatile and trusted delivery format in the cholesterol control supplement market, driving both consumer preference and manufacturer focus
For instance:
As per product type, the industry has been categorized into Omega-3 Fatty Acids (Fish oil, Algal oil), Plant Sterols/Stanols, Fiber Supplements (Psyllium, Beta-Glucan), Niacin (Vitamin B3)
As per Form, the industry has been categorized into Capsules, Tablets, Softgels, Powders, Gummies, Liquid Drops, Chewables.
As per Form, the industry has been categorized into Plant-Based (Herbal extracts, Sterols, etc.), Animal-Based (Fish oil, Omega-3), Synthetic (Lab-formulated niacin, etc.), Organic/Natural
As per End Use, the industry has been categorized into Pharmacies, Supermarkets/Hypermarkets, Online Retail, Health & Wellness Stores, Specialty Supplement Stores, Direct Sales (Subscription services, MLM)
As per Sales Channel, the industry has been categorized into LDL Cholesterol Reduction, HDL Cholesterol Enhancement, Triglyceride Management, Cardiovascular Health Support, Arterial Plaque Reduction, Blood Pressure Management
Industry analysis has been carried out in key countries of North America, Latin America, Western Europe, Eastern Balkans & Baltic, Russia & Belarus, Central Asia, East Asia, South Asia, and the Middle East & Africa.
The global industry is estimated at a value of USD 1,021.01 million in 2024.
Sales increased at 3.1 % CAGR between 2019 and 2023.
Some of the leaders in this industry include Himalaya Wellness Company, Croda International Plc, Inlife Pharma Private Limite, Pure Encapsulations LLC, HERBAL CREATIONS
The North America territory is projected to hold a revenue share of 35.8 % over the forecast period.
The industry is projected to grow at a forecast CAGR of 4.6 % from 2024 to 2034.
1. Executive Summary 2. Industry Introduction, Including Taxonomy and Market Definition 3. Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. By Product Type 6.2. By Product Forms 6.3. By Ingredients Source 6.4. By Sales Channel 6.5. By Functionality 6.6. By Geography 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 7.1. Omega-3 Fatty Acids (Fish oil, Algal oil) 7.2. Plant Sterols/Stanols 7.3. Fiber Supplements (Psyllium, Beta-Glucan) 7.4. Niacin (Vitamin B3) 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Forms 8.1. Capsules 8.2. Tablets 8.3. Softgels 8.4. Powders 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Ingredients Source 9.1. Plant-Based (Herbal extracts, Sterols, etc.) 9.2. Animal-Based (Fish oil, Omega-3) 9.3. Synthetic (Lab-formulated niacin, etc.) 9.4. Organic/Natural 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sales Channel 10.1. Online Retail 10.2. Offline Retail 10.2.1. Supermarkets/Hypermarkets 10.2.2. Specialty Stores 10.2.3. Pharmacies 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Functionality 11.1. LDL Cholesterol Reduction 11.2. HDL Cholesterol Enhancement 11.3. Triglyceride Management 11.4. Cardiovascular Health Support 11.5. Arterial Plaque Reduction 11.6. Blood Pressure Management 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Geography 12.1. North America 12.2. Latin America 12.3. Western Europe 12.4. Eastern Europe 12.5. Balkans & Baltic 12.6. Russia & Belarus 12.7. Central Asia 12.8. East Asia 12.9. South Asia & Pacific 12.10. Middle East & Africa 13. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Balkans & Baltic Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Russia & Belarus Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. Central Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 20. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 21. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 22. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 23. Sales Forecast 2024 to 2034 By Product Type, By Product Forms, By Ingredients Source, and By Sales Channel, By Functionality for 30 Countries 24. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 25. Company Profile 25.1. Streamline Pharma Pvt. Ltd. 25.2. Himalaya Wellness Company 25.3. Croda International Plc 25.4. Inlife Pharma Private Limited 25.5. Pure Encapsulations LLC 25.6. HERBAL CREATIONS 25.7. ORGANIC INDIA Pvt. Ltd. 25.8. Step One Foods 25.9. TCI Co. Ltd. 25.10. Cargill
Explore Food and Beverage Insights
View Reports
Cholesterol Control Supplements Market
